UDP-glucose, Highly P2Y14 agonist (ab120384)
Key features and details
- Highly potent P2Y14 agonist
- CAS Number: 28053-08-9
- Soluble in water to 100 mM
- Form / State: Solid
- Source: Synthetic
Overview
-
Product name
UDP-glucose, Highly P2Y14 agonist -
Description
Highly potent P2Y14 agonist -
Alternative names
- UDP-glc
- Uridine 5'-diphosphoglucose
- Uridine-diphosphate-glucose disodium salt
-
Biological description
Highly potent, endogenous P2Y14 agonist (EC50 = 82 nM). Involved in modulation of gastric function. UDP also available (ab120383).
-
CAS Number
28053-08-9 -
Chemical structure
Properties
-
Chemical name
Uridine 5'-diphosphoglucose disodium salt -
Molecular weight
610.27 -
Molecular formula
C15H22N2Na2O17P2 -
PubChem identifier
119803 -
Storage instructions
Store at -20°C. Store under desiccating conditions. The product can be stored for up to 12 months. -
Solubility overview
Soluble in water to 100 mM -
Handling
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
-
SMILES
O=C1C=CN(C(=O)N1)[C@@H]3O[C@H](COP(=O)(OP(=O)(O[C@@H]2OC(CO)[C@@H](O)[C@@H](O)[C@@H]2O)O[Na])O[Na])[C@@H](O)[C@H]3O -
Source
Synthetic
-
Research areas
Protocols
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
References (2)
ab120384 has been referenced in 2 publications.
- Anderson CJ et al. Microbes exploit death-induced nutrient release by gut epithelial cells. Nature 596:262-267 (2021). PubMed: 34349263
- Li Q et al. The Protein Phosphatase 1 Complex Is a Direct Target of AKT that Links Insulin Signaling to Hepatic Glycogen Deposition. Cell Rep 28:3406-3422.e7 (2019). PubMed: 31553910